Charles Berg Davita Inc. (DVA) insider trading activity

Charles Berg is Director of DAVITA INC.. Currently has a direct ownership of 19,285 shares of DVA, which is worth approximately $2.89 Million. The most recent transaction as insider was on Nov 15, 2024, when has been sold 312 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.3K

1.64% 3M change

7.67% 12M change

Total Value Held $2.89 Million

CHARLES BERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 15 2024	BUY Grant, award, or other acquisition	-	312 Added 1.59%	19,285 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	333 Added 1.72%	18,973 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	363 Added 1.91%	18,640 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	366 Added 1.96%	18,277 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	529 Added 2.87%	17,911 Common Stock
Aug 15 2023	BUY Grant, award, or other acquisition	-	475 Added 2.66%	17,382 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	516 Added 2.96%	16,907 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	658 Added 3.86%	16,391 Common Stock
Mar 09 2023	SELL Open market or private sale	$107,511 $75.13 p/Share	1,431 Reduced 8.34%	15,733 Common Stock
Mar 01 2023	SELL Open market or private sale	$60,108 $81.78 p/Share	735 Reduced 4.11%	17,164 Common Stock
Feb 28 2023	SELL Sale (or disposition) back to the issuer	$475,004 $82.84 p/Share	5,734 Reduced 24.26%	17,899 Common Stock
Feb 28 2023	BUY Exercise of conversion of derivative security	$474,967 $66.29 p/Share	7,165 Added 23.26%	23,633 Common Stock
Feb 24 2023	SELL Sale (or disposition) back to the issuer	$237,505 $82.87 p/Share	2,866 Reduced 14.82%	16,468 Common Stock
Feb 24 2023	BUY Exercise of conversion of derivative security	$237,449 $65.94 p/Share	3,601 Added 15.7%	19,334 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	-	677 Added 4.13%	15,733 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	514 Added 3.3%	15,056 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	475 Added 3.16%	14,542 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	429 Added 2.96%	14,067 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	446 Added 3.17%	13,638 Common Stock
Aug 15 2021	BUY Grant, award, or other acquisition	-	365 Added 2.69%	13,192 Common Stock
May 15 2021	BUY Grant, award, or other acquisition	-	379 Added 2.87%	12,827 Common Stock
May 04 2021	SELL Sale (or disposition) back to the issuer	$380,052 $120.92 p/Share	3,143 Reduced 18.0%	14,320 Common Stock
May 04 2021	SELL Open market or private sale	$229,357 $122.52 p/Share	1,872 Reduced 13.07%	12,448 Common Stock
May 04 2021	BUY Exercise of conversion of derivative security	$379,987 $75.77 p/Share	5,015 Added 22.31%	17,463 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	436 Added 3.38%	12,448 Common Stock

Also insider at

TALK

Talkspace, Inc. Healthcare

Cigna Corp Healthcare

Pres, Govt Programs & Sr Advsr

Charles Berg

Director

Denver, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVA shares.

Notify only if

Value

Insider Trading

Get notified when an Davita Inc. insider buys or sells DVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to DAVITA INC.

Track Activities on DVA

Account